Literature DB >> 8606107

Mycobacterium tuberculosis invades and replicates within type II alveolar cells.

L E Bermudez1, J Goodman.   

Abstract

Although Mycobacterium tuberculosis is assumed to infect primarily alveolar macrophages after being aspirated into the lung in aerosol form, it is plausible to hypothesize that M. tuberculosis can come in contact with alveolar epithelial cells upon arrival into the alveolar space. Therefore, as a first step toward investigation of the interaction between M. tuberculosis and alveolar epithelial cells, we examined the ability of M. tuberculosis to bind to and invade alveolar epithelial cells in vitro. The H37Rv and H37Ra strains of M. tuberculosis were cultured to mid-log phase and used in both adherence and invasion assays. The A549 human type II alveolar cell line was cultured to confluence in RPMI 1640 supplemented with 5% fetal bovine serum, L-glutamine, and nonessential amino acids. H37Rv was more efficient in entering A549 cells than H37Ra, Mycobacterium avium, and Escherichia coli Hb101, and nonpiliated strain (4.7% +/- 1.0% of the initial inoculum in 2 h compared with 3.1% +/- 0.8%, 2.1% +/- 0.9%, and 0.03% +/- 0.0%, respectively). The invasion was more efficient at 37 degrees C than 30 degrees C (4.7% +/- 1.0% compared with 2.3% +/- 0.8%). H37Rv and H37Ra were both capable of multiplying intracellularly at a similar ration over 4 days. Binding was inhibited up to 55.7% by anti-CD51 antibody (antivitronectin receptor), up to 55% with anti-CD29 antibody (beta(1) integrin), and 79% with both antibodies used together. Update of M. tuberculosis H37Rv was microtubule and microfilament dependent. It was inhibited by 6l.4% in the presence of 10 micron colchicine and by 72.3% in the presence of 3 micron cytochalasin D, suggesting two separate pathways for uptake. Our results show that M. tuberculosis is capable of invading type II alveolar epithelial cells and raise the possibility that invasion of alveolar epithelial cells is associated with the pathogenesis of lung infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606107      PMCID: PMC173932          DOI: 10.1128/iai.64.4.1400-1406.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Phagocytosis by HeLa cells and their susceptibility to infection by human tubercle bacilli.

Authors:  C C SHEPARD
Journal:  Proc Soc Exp Biol Med       Date:  1955-11

2.  A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12.

Authors:  R R Isberg; S Falkow
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

3.  Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells.

Authors:  V L Miller; S Falkow
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

Review 4.  Endocytosis and the recycling of plasma membrane.

Authors:  R M Steinman; I S Mellman; W A Muller; Z A Cohn
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

5.  Pathogenesis of pulmonary tuberculosis.

Authors:  A M Dannenberg
Journal:  Am Rev Respir Dis       Date:  1982-03

6.  Cell number and cell characteristics of the normal human lung.

Authors:  J D Crapo; B E Barry; P Gehr; M Bachofen; E R Weibel
Journal:  Am Rev Respir Dis       Date:  1982-06

7.  Analysis of expression and thermoregulation of the Yersinia pseudotuberculosis inv gene with hybrid proteins.

Authors:  R R Isberg; A Swain; S Falkow
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

8.  In vitro interaction of Mycobacterium avium with intestinal epithelial cells.

Authors:  M E Mapother; J G Songer
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

9.  Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals.

Authors:  D W Smith; E Wiegeshaus; R Navalkar; A A Grover
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

10.  Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.

Authors:  T L Ratliff; J O Palmer; J A McGarr; E J Brown
Journal:  Cancer Res       Date:  1987-04-01       Impact factor: 12.701

View more
  137 in total

1.  Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.

Authors:  Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Keisuke Sano; Toshiaki Shimizu
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

3.  Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.

Authors:  H Tomioka; K Sato; H Kajitani; T Akaki; S Shishido
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Mycobacterium tuberculosis Rv2536 protein implicated in specific binding to human cell lines.

Authors:  Javier García; Alvaro Puentes; Luis Rodríguez; Marisol Ocampo; Hernando Curtidor; Ricardo Vera; Ramses Lopez; John Valbuena; Jimena Cortes; Magnolia Vanegas; Carlos Barrero; Manuel A Patarroyo; Mauricio Urquiza; Manuel E Patarroyo
Journal:  Protein Sci       Date:  2005-09       Impact factor: 6.725

5.  Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent.

Authors:  C Cywes; H C Hoppe; M Daffé; M R Ehlers
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

6.  Capture of heat-killed Mycobacterium bovis bacillus Calmette-Guérin by intelectin-1 deposited on cell surfaces.

Authors:  Shoutaro Tsuji; Makiko Yamashita; Donald R Hoffman; Akihito Nishiyama; Tsutomu Shinohara; Takashi Ohtsu; Yoshimi Shibata
Journal:  Glycobiology       Date:  2009-01-29       Impact factor: 4.313

Review 7.  Alveolar Epithelial Cells in Mycobacterium tuberculosis Infection: Active Players or Innocent Bystanders?

Authors:  Julia M Scordo; Daren L Knoell; Jordi B Torrelles
Journal:  J Innate Immun       Date:  2015-09-18       Impact factor: 7.349

8.  Porphyromonas gingivalis fimbriae use beta2 integrin (CD11/CD18) on mouse peritoneal macrophages as a cellular receptor, and the CD18 beta chain plays a functional role in fimbrial signaling.

Authors:  A Takeshita; Y Murakami; Y Yamashita; M Ishida; S Fujisawa; S Kitano; S Hanazawa
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Mycobacterium avium-intracellulare contamination of mammalian cell cultures.

Authors:  I H Lelong-Rebel; Y Piemont; M Fabre; G Rebel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

10.  The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages.

Authors:  Richard W Stokes; Raymond Norris-Jones; Donald E Brooks; Terry J Beveridge; Dan Doxsee; Lisa M Thorson
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.